415 related articles for article (PubMed ID: 29727401)
41. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
[TBL] [Abstract][Full Text] [Related]
42. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
[TBL] [Abstract][Full Text] [Related]
43. T1 signal intensity in the dentate nucleus after the administration of the macrocyclic gadolinium-based contrast agent gadoterate meglumine: An observational study.
Ramalho J; Semelka RC; Cruz J; Morais T; Ramalho M
Radiologia (Engl Ed); 2022; 64(5):397-406. PubMed ID: 36243439
[TBL] [Abstract][Full Text] [Related]
44. Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents.
Zhang Y; Cao Y; Shih GL; Hecht EM; Prince MR
Radiology; 2017 Feb; 282(2):516-525. PubMed ID: 27513848
[TBL] [Abstract][Full Text] [Related]
45. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
[TBL] [Abstract][Full Text] [Related]
46. MRI and Quantitative Magnetic Susceptibility Maps of the Brain after Serial Administration of Gadobutrol: A Longitudinal Follow-up Study.
Choi Y; Jang J; Kim J; Nam Y; Shin NY; Ahn KJ; Jeon SS; Kim BS
Radiology; 2020 Oct; 297(1):143-150. PubMed ID: 32692298
[TBL] [Abstract][Full Text] [Related]
47. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population.
Gulino P; Bianchi A; Diciotti S; Scionti A; Sali L; Papadopulos P; Mascalchi M
Acta Radiol; 2021 Mar; 62(3):368-376. PubMed ID: 32529894
[TBL] [Abstract][Full Text] [Related]
48. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
Kasper E; Schemuth HP; Horry S; Kinner S
Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
[TBL] [Abstract][Full Text] [Related]
49. Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
Eisele P; Alonso A; Szabo K; Ebert A; Ong M; Schoenberg SO; Gass A
Medicine (Baltimore); 2016 Sep; 95(39):e4624. PubMed ID: 27684794
[TBL] [Abstract][Full Text] [Related]
50. Gadolinium deposition in the paediatric brain: T1-weighted hyperintensity within the dentate nucleus following repeated gadolinium-based contrast agent administration.
Young JR; Orosz I; Franke MA; Kim HJ; Woodworth D; Ellingson BM; Salamon N; Pope WB
Clin Radiol; 2018 Mar; 73(3):290-295. PubMed ID: 29208312
[TBL] [Abstract][Full Text] [Related]
51. Switching from linear to macrocyclic gadolinium-based contrast agents halts the relative T
Rowe SK; Rodriguez D; Cohen E; Grundy R; Morgan PS; Jaspan T; Dineen RA
J Magn Reson Imaging; 2020 Jan; 51(1):288-295. PubMed ID: 31165554
[TBL] [Abstract][Full Text] [Related]
52. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.
Hu HH; Pokorney A; Towbin RB; Miller JH
Pediatr Radiol; 2016 Oct; 46(11):1590-8. PubMed ID: 27282825
[TBL] [Abstract][Full Text] [Related]
53. Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study.
Topcuoglu ED; Topcuoglu OM; Semiz Oysu A; Bukte Y
J Magn Reson Imaging; 2020 May; 51(5):1471-1477. PubMed ID: 31665554
[TBL] [Abstract][Full Text] [Related]
54. Dentate nucleus signal intensity changes on T1-weighted MRI after repeated administrations of linear and macrocyclic gadolinium-based contrast agents: a pediatric intraindividual case-control study.
Ozturk K; Nascene D
Acta Radiol; 2022 Jul; 63(7):914-922. PubMed ID: 34018821
[TBL] [Abstract][Full Text] [Related]
55. Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter : Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis.
Hannoun S; Kocevar G; Codjia P; Maucort-Boulch D; Cotton F; Vukusic S; Durand-Dubief F; Sappey-Marinier D
Clin Neuroradiol; 2022 Sep; 32(3):677-685. PubMed ID: 33630120
[TBL] [Abstract][Full Text] [Related]
56. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent.
Ozturk K; Nascene D
AJNR Am J Neuroradiol; 2021 Jun; 42(6):1136-1143. PubMed ID: 33888459
[TBL] [Abstract][Full Text] [Related]
57. Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid.
Ichikawa S; Motosugi U; Omiya Y; Onishi H
Invest Radiol; 2017 Jul; 52(7):389-395. PubMed ID: 28195932
[TBL] [Abstract][Full Text] [Related]
58. Dentate Nucleus Signal Intensity Decrease on T1-weighted MR Images after Switching from Gadopentetate Dimeglumine to Gadobutrol.
Behzadi AH; Farooq Z; Zhao Y; Shih G; Prince MR
Radiology; 2018 Jun; 287(3):816-823. PubMed ID: 29533723
[TBL] [Abstract][Full Text] [Related]
59. Measurements of signal intensity of globus pallidus and dentate nucleus suggest different deposition characteristics of macrocyclic GBCAs in children.
Olchowy C; Maciąg EJ; Sanchez-Montanez A; Olchowy A; Delgado I; Vazquez E
PLoS One; 2018; 13(12):e0208589. PubMed ID: 30586415
[TBL] [Abstract][Full Text] [Related]
60. Is There Long-term Signal Intensity Increase in the Central Nervous System on T1-weighted Images after MR Imaging with the Hepatospecific Contrast Agent Gadoxetic Acid? A Cross-sectional Study in 91 Patients.
Kahn J; Posch H; Steffen IG; Geisel D; Bauknecht C; Liebig T; Denecke T
Radiology; 2017 Mar; 282(3):708-716. PubMed ID: 28076722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
